Literature DB >> 15753675

Epidemiology of thyroid microcarcinoma found in autopsy series conducted in areas of different iodine intake.

Gábor L Kovács1, Gábor Gonda, Gizella Vadász, Eva Ludmány, Katalin Uhrin, Zoltán Görömbey, László Kovács, Erika Hubina, Miklós Bodó, Miklós I Góth, István Szabolcs.   

Abstract

The prevalence of thyroid microcarcinomas found at autopsies is 100-1000 times higher than in clinical cancer. The epidemiological and histological characteristics of thyroid microcarcinomas in consecutive series of autopsies performed in two areas of different iodine intake were investigated. Iodine deficient (ID) area: n = 222 (M = 109, F = 113), median age: 74-76 years, median iodine excretion (MIE) of nursing home residents from this area: 70 microg/g creatinine. Iodine sufficient (IS) area: n = 221 (M = 132, F = 89), median age: 68 years, MIE: 500 microg/g creatinine. When compared to the IS area, the results obtained in the ID area showed a higher thyroid weight (mean 27.75 g +/- 18.43 g vs. 16.5 g +/- 9.6 g, p < 0.0001) and a larger number of goitrous glands (50/222 vs. 5/221, p < 0.0001). Altogether 21 microcarcinomas were found (4.74%) with no iodine intake- or gender-related difference: ID n = 11 (4.95%), M/F = 8/3; IS n = 10 (4.52%), M/F = 6/4. Microcarcinomas seemed to be more prevalent in the 40-59-year age group. All microcarcinomas were of the papillary type. In conclusion, compared to clinical cancer, thyroid microcarcinomas are characterized by a two-scale higher prevalence, are not related to iodine intake, gender or nodularity, are most exclusively of the papillary type.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15753675     DOI: 10.1089/thy.2005.15.152

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  17 in total

Review 1.  Thyroid cancer, thyroiditis and dietary iodine: a review based on the Salta, Argentina model.

Authors:  H Rubén Harach; Gustavo A Ceballos
Journal:  Endocr Pathol       Date:  2008       Impact factor: 3.943

2.  Rising incidence of thyroid cancer in Serbia.

Authors:  N Slijepcevic; V Zivaljevic; I Paunovic; A Diklic; Perisic Zivkovic; D Miljus; A Grgurevic; S Sipetic
Journal:  Hippokratia       Date:  2016 Jan-Mar       Impact factor: 0.471

Review 3.  Thyroid nodules.

Authors:  Geanina Popoveniuc; Jacqueline Jonklaas
Journal:  Med Clin North Am       Date:  2012-03       Impact factor: 5.456

Review 4.  Thyroid follicular microcarcinoma.

Authors:  Andrea Casaril; Marco Inama; Harmony Impellizzeri; Matilde Bacchion; Mihail Creciun; Gianluigi Moretto
Journal:  Gland Surg       Date:  2020-01

Review 5.  Occult thyroid carcinoma.

Authors:  J Boucek; J Kastner; J Skrivan; E Grosso; B Gibelli; G Giugliano; J Betka
Journal:  Acta Otorhinolaryngol Ital       Date:  2009-12       Impact factor: 2.124

Review 6.  Screening for cancer with molecular markers: progress comes with potential problems.

Authors:  John A Baron
Journal:  Nat Rev Cancer       Date:  2012-04-12       Impact factor: 60.716

7.  Prevalence of Subclinical Papillary Thyroid Cancer by Age: Meta-analysis of Autopsy Studies.

Authors:  Natalia Arroyo; Katy J L Bell; Vivian Hsiao; Sara Fernandes-Taylor; Oguzhan Alagoz; Yichi Zhang; Louise Davies; David O Francis
Journal:  J Clin Endocrinol Metab       Date:  2022-09-28       Impact factor: 6.134

8.  Changes in the clinicopathological characteristics and outcomes of thyroid cancer in Korea over the past four decades.

Authors:  Bo Youn Cho; Hoon Sung Choi; Young Joo Park; Jung Ah Lim; Hwa Young Ahn; Eun Kyung Lee; Kyung Won Kim; Ka Hee Yi; June-Key Chung; Yeo-Kyu Youn; Nam Han Cho; Do Joon Park; Chang-Soon Koh
Journal:  Thyroid       Date:  2013-06-21       Impact factor: 6.568

9.  Surgical treatment of substernal goiter: an analysis of 59 patients.

Authors:  Ayman Agha; Gabriel Glockzin; Nabil Ghali; Igors Iesalnieks; Hans J Schlitt
Journal:  Surg Today       Date:  2008-05-31       Impact factor: 2.549

10.  Thyroid cancer: burden of illness and management of disease.

Authors:  Rebecca L Brown; Jonas A de Souza; Ezra Ew Cohen
Journal:  J Cancer       Date:  2011-04-04       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.